Dr. Shirley D’Sa discusses how treatment strategies for WM have evolved over the course of her career.
Dr. Shirley D'Sa
Advertisement
D'Sa is a consultant hematologist and clinical lead for the University College London Hospital (UCLH) Centre for Waldenström’s Macroglobulinemia and Associated Disorders, as well as an honorary associate professor at the UCL Cancer Institute. She also serves as the hematological lead in the joint neurohematology service at the National Hospital for Neurology, Queen Square, London.
Articles by Dr. Shirley D'Sa
Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenström macroglobulinemia early on and how to treat it.
Advertisement
Latest Updated Articles
Mitigating Peripheral Neuropathy During Cancer TreatmentPublished: May 5th 2025 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Body Image and Sexual Health Challenges After Breast Cancer
2
What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma
3
Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery
4
What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?
5
